THE IMPACT OF BARIATRIC SURGERY ON COLORECTAL CANCER RISK


  • Finucane MM, Stevens GA, Cowan MJ, et al. Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass Index). National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants. Lancet. 2011 Feb 12;377(9765):557-567. doi: 10.1016/S0140-6736(10)62037-5. Epub 2011 Feb 3. PMID: 21295846; PMCID: PMC4472365.

  • GBD 2015 Obesity Collaborators. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med. 2017 Jul 6;377(1):13-27. doi: 10.1056/NEJMoa1614362. Epub 2017 Jun 12. PMID: 28604169; PMCID: PMC5477817.

    • Finkelstein E.A.
    • Khavjou O.A.
    • Thompson H.
    • et al.

    Obesity and severe obesity forecasts through 2030.

    Am J Prev Med. 2012 Jun; 42 (): 563-570https://doi.org/10.1016/j.amepre.2011.10.026

  • Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013 Jan 2;309(1):71-82. doi: 10.1001/jama.2012.113905. PMID: 23280227; PMCID: PMC4855514.

    • Guh D.P.
    • Zhang W.
    • Bansback N.
    • Amarsi Z.
    • Birmingham C.L.
    • Anis A.H.

    The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis.

    BMC Public Health. 2009 Mar 25; 9 (): 88https://doi.org/10.1186/1471-2458-9-88

    • Polyzos S.A.
    • Kountouras J.
    • Mantzoros C.S.

    Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics.

    Metabolism. 2019 Mar; 92 (): 82-97https://doi.org/10.1016/j.metabol.2018.11.014

  • Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008 Feb 16;371(9612):569-578. doi: 10.1016/S0140-6736(08)60269-X. PMID: 18280327.

  • Di Lorenzo N, Antoniou SA, Batterham RL, et al. Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC, EASO and ESPCOP. Surg Endosc. 2020 Jun;34(6):2332-2358. doi: 10.1007/s00464-020-07555-y. Epub 2020 Apr 23. PMID: 32328827; PMCID: PMC7214495.

  • Fried M, Yumuk V, Oppert JM, et al. International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC); European Association for the Study of Obesity (EASO); European Association for the Study of Obesity Obesity Management Task Force (EASO OMTF). Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Surg. 2014 Jan;24(1):42-55. doi: 10.1007/s11695-013-1079-8. PMID: 24081459.

  • Buchwald H, Williams SE. Bariatric surgery worldwide 2003. Obes Surg. 2004 Oct;14(9):1157-1164. doi: 10.1381/0960892042387057. PMID: 15527627.

  • Angrisani L, Santonicola A, Iovino P, Ramos A, Shikora S, Kow L. Bariatric Surgery Survey 2018: Similarities and Disparities Among the 5 IFSO Chapters. Obes Surg. 2021 May;31(5):1937-1948. doi: 10.1007/s11695-020-05207-7. Epub 2021 Jan 12. PMID: 33432483; PMCID: PMC7800839.

  • Sheng B, Truong K, Spitler H, Zhang L, Tong X, Chen L. The Long-Term Effects of Bariatric Surgery on Type 2 Diabetes Remission, Microvascular and Macrovascular Complications, and Mortality: a Systematic Review and Meta-Analysis. Obes Surg. 2017 Oct;27(10):2724-2732. doi: 10.1007/s11695-017-2866-4. PMID: 28801703.

  • Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004 Oct 13;292(14):1724-1737. doi: 10.1001/jama.292.14.1724. Erratum in: JAMA. 2005 Apr 13;293(14):1728. PMID: 15479938.

  • Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013 Oct 22;347:f5934. doi: 10.1136/bmj.f5934. PMID: 24149519; PMCID: PMC3806364.

  • Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009 Mar;122(3):248-256.e5. doi: 10.1016/j.amjmed.2008.09.041. PMID: 19272486.

  • Sutanto A, Wungu CDK, Susilo H, Sutanto H. Reduction of Major Adverse Cardiovascular Events (MACE) after Bariatric Surgery in Patients with Obesity and Cardiovascular Diseases: A Systematic Review and Meta-Analysis. Nutrients. 2021 Oct 12;13(10):3568. doi: 10.3390/nu13103568. PMID: 34684569; PMCID: PMC8537443.

  • Castagneto-Gissey L, Casella-Mariolo J, Casella G, Mingrone G. Obesity Surgery and Cancer: What Are the Unanswered Questions? Front Endocrinol (Lausanne). 2020 Apr 15;11:213. doi: 10.3389/fendo.2020.00213. PMID: 32351453; PMCID: PMC7174700.

    • Ashrafian H.
    • Ahmed K.
    • Rowland S.P.
    • et al.

    Metabolic surgery and cancer: protective effects of bariatric procedures.

    Cancer. 2011 May 1; 117 (): 1788-1799https://doi.org/10.1002/cncr.25738

  • Schauer DP, Feigelson HS, Koebnick C, et al. Bariatric Surgery and the Risk of Cancer in a Large Multisite Cohort. Ann Surg. 2019 Jan;269(1):95-101. doi: 10.1097/SLA.0000000000002525. PMID: 28938270; PMCID: PMC6201282.

  • Tao W, Santoni G, von Euler-Chelpin M, et al. Cancer Risk After Bariatric Surgery in a Cohort Study from the Five Nordic Countries. Obes Surg. 2020 Oct;30(10):3761-3767. doi: 10.1007/s11695-020-04751-6. Epub 2020 Jun 13. PMID: 32535785; PMCID: PMC7467909.

  • Wiggins T, Antonowicz SS, Markar SR. Cancer Risk Following Bariatric Surgery-Systematic Review and Meta-analysis of National Population-Based Cohort Studies. Obes Surg. 2019 Mar;29(3):1031-1039. doi: 10.1007/s11695-018-3501-8. PMID: 30591985.

  • Afshar S, Kelly SB, Seymour K, Lara J, Woodcock S, Mathers JC. The effects of bariatric surgery on colorectal cancer risk: systematic review and meta-analysis. Obes Surg. 2014 Oct;24(10):1793-1799. doi: 10.1007/s11695-014-1359-y. PMID: 25015708

    • Ciccioriccio M.C.
    • Iossa A.
    • Boru C.E.
    • et al.

    CRIC-ABS 2020 GROUP. Colorectal cancer after bariatric surgery (Cric-Abs 2020): Sicob (Italian society of obesity surgery) endorsed national survey.

    Int J Obes (Lond). 2021 Dec; 45 (): 2527-2531https://doi.org/10.1038/s41366-021-00910-6

    • Mackenzie H.
    • Markar S.R.
    • Askari A.
    • et al.

    Obesity surgery and risk of cancer.

    Br J Surg. 2018 Nov; 105 (): 1650-1657https://doi.org/10.1002/bjs.10914

    • Derogar M.
    • Hull M.A.
    • Kant P.
    • Östlund M.
    • Lu Y.
    • Lagergren J.

    Increased risk of colorectal cancer after obesity surgery.

    Ann Surg. 2013 Dec; 258 (): 983-988https://doi.org/10.1097/SLA.0b013e318288463a

    • Sung H.
    • Ferlay J.
    • Siegel R.L.
    • et al.

    Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

    CA Cancer J Clin. 2021 May; 71 (): 209-249https://doi.org/10.3322/caac.21660

    • Mármol I.
    • Sánchez-de-Diego C.
    • Pradilla Dieste A.
    • Cerrada E.
    • Rodriguez Yoldi M.J.

    Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer.

    Int J Mol Sci. 2017 Jan 19; 18 (): 197https://doi.org/10.3390/ijms18010197

  • Dai Z, Xu YC, Niu L. Obesity and colorectal cancer risk: a meta-analysis of cohort studies. World J Gastroenterol. 2007 Aug 21;13(31):4199-4206. doi: 10.3748/wjg.v13.i31.4199. PMID: 17696248; PMCID: PMC4250618.

    • Schwingshackl L.
    • Schwedhelm C.
    • Hoffmann G.
    • et al.

    Food groups and risk of colorectal cancer.

    Int J Cancer. 2018 May 1; 142 (): 1748-1758https://doi.org/10.1002/ijc.31198

  • McNabb S, Harrison TA, Albanes D, et al. Meta-analysis of 16 studies of the association of alcohol with colorectal cancer. Int J Cancer. 2020 Feb 1;146(3):861-873. doi: 10.1002/ijc.32377. Epub 2019 Jun 7. PMID: 31037736; PMCID: PMC6819207.

  • Liang PS, Chen TY, Giovannucci E. Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int J Cancer. 2009 May 15;124(10):2406-2415. doi: 10.1002/ijc.24191. PMID: 19142968.

  • Wolfe BM, Kvach E, Eckel RH. Treatment of Obesity: Weight Loss and Bariatric Surgery. Circ Res. 2016 May 27;118(11):1844-1855. doi: 10.1161/CIRCRESAHA.116.307591. PMID: 27230645; PMCID: PMC4888907.

    • Phillips B.T.
    • Shikora S.A.

    The history of metabolic and bariatric surgery: Development of standards for patient safety and efficacy.

    Metabolism. 2018 Feb; 79 (): 97-107https://doi.org/10.1016/j.metabol.2017.12.010

  • Aarts EO, Mahawar K. From the Knife to the Endoscope-a History of Bariatric Surgery. Curr Obes Rep. 2020 Sep;9(3):348-363. doi: 10.1007/s13679-020-00382-1. PMID: 32462537.

    • Welbourn R.
    • Hollyman M.
    • Kinsman R.
    • et al.

    Bariatric Surgery Worldwide: Baseline Demographic Description and One-Year Outcomes from the Fourth IFSO Global Registry Report 2018.

    Obes Surg. 2019 Mar; 29 (): 782-795https://doi.org/10.1007/s11695-018-3593-1

  • Mechanisms underlying the weight loss effects of RYGB and SG: similar, yet different.

    J Endocrinol Invest. 2019 Feb; 42 (): 117-128https://doi.org/10.1007/s40618-018-0892-2

  • Wiggins T, Majid MS, Agrawal S. From the Knife to the Endoscope-a History of Bariatric Surgery. Curr Obes Rep. 2020 Sep;9(3):315-325. doi: 10.1007/s13679-020-00386-x. PMID: 32430773.

  • Robert M, Espalieu P, Pelascini E, et al. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial. Lancet. 2019 Mar 30;393(10178):1299-1309. doi: 10.1016/S0140-6736(19)30475-1. Epub 2019 Mar 6. Erratum in: Lancet. 2019 Mar 30;393(10178):1298. PMID: 30851879.

    • Ostlund M.P.
    • Lu Y.
    • Lagergren J.

    Risk of obesity-related cancer after obesity surgery in a population-based cohort study.

    Ann Surg. 2010 Dec; 252 (): 972-976https://doi.org/10.1097/SLA.0b013e3181e33778

    • Tao W.
    • Artama M.
    • von Euler-Chelpin M.
    • Hull M.
    • Ljung R.
    • Lynge E.
    • Ólafsdóttir G.H.
    • Pukkala E.
    • Romundstad P.
    • Talbäck M.
    • Tryggvadottir L.
    • Lagergren J.

    Colon and rectal cancer risk after bariatric surgery in a multicountry Nordic cohort study.

    Int J Cancer. 2020 Aug 1; 147 (): 728-735https://doi.org/10.1002/ijc.32770

  • Hussan H, Drosdak A, Le Roux M et al. The Long-term Impact of Roux-en-Y Gastric Bypass on Colorectal Polyp Formation and Relation to Weight Loss Outcomes. Obes Surg. 2020 Feb;30(2):407-415. doi: 10.1007/s11695-019-04176-w. PMID: 31646474.

  • Tao W, Konings P, Hull MA, Adami HO, Mattsson F, Lagergren J. Colorectal Cancer Prognosis Following Obesity Surgery in a Population-Based Cohort Study. Obes Surg. 2017 May;27(5):1233-1239. doi: 10.1007/s11695-016-2431-6. PMID: 27822767; PMCID: PMC5403840.

  • Aravani A, Downing A, Thomas JD, Lagergren J, Morris EJA, Hull MA. Obesity surgery and risk of colorectal and other obesity-related cancers: An English population-based cohort study. Cancer Epidemiol. 2018 Apr;53:99-104. doi: 10.1016/j.canep.2018.01.002. Epub 2018 Feb 3. PMID: 29414638; PMCID: PMC5865073.

  • Biomarkers of increased susceptibility to gastrointestinal cancer: new application to studies of cancer prevention in human subjects.

    Cancer Res. 1988 Jan 15; 48 (): 235-245

  • Wong WM, Mandir N, Goodlad RA, et al. Histogenesis of human colorectal adenomas and hyperplastic polyps: the role of cell proliferation and crypt fission. Gut. 2002 Feb;50(2):212-217. doi: 10.1136/gut.50.2.212. PMID: 11788562; PMCID: PMC1773120.

    • Sainsbury A.
    • Goodlad R.A.
    • Perry S.L.
    • Pollard S.G.
    • Robins G.G.
    • Hull M.A.

    Increased colorectal epithelial cell proliferation and crypt fission associated with obesity and roux-en-Y gastric bypass.

    Cancer Epidemiol Biomarkers Prev. 2008 Jun; 17 (): 1401-1410https://doi.org/10.1158/1055-9965.EPI-07-2874

    • Gordon-Weeks A.N.
    • Lim S.Y.
    • Yuzhalin A.E.
    • Jones K.
    • Muschel R.

    Macrophage migration inhibitory factor: a key cytokine and therapeutic target in colon cancer.

    Cytokine Growth Factor Rev. 2015 Aug; 26 (): 451-461https://doi.org/10.1016/j.cytogfr.2015.03.002

  • De Simone V, Franzè E, Ronchetti G, et al. Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth. Oncogene. 2015 Jul;34(27):3493-3503. doi: 10.1038/onc.2014.286. Epub 2014 Sep 1. PMID: 25174402; PMCID: PMC4493653.

  • Negi RR, Rana SV, Gupta V, Gupta R, Chadha VD, Prasad KK, Dhawan DK. Over-Expression of Cyclooxygenase-2 in Colorectal Cancer Patients. Asian Pac J Cancer Prev. 2019 Jun 1;20(6):1675-1681. doi: 10.31557/APJCP.2019.20.6.1675. PMID: 31244287; PMCID: PMC7021602.

    • Liu Y.
    • Sun H.
    • Hu M.
    • Zhang Y.
    • Chen S.
    • Tighe S.
    • Zhu Y.

    The Role of Cyclooxygenase-2 in Colorectal Carcinogenesis.

    Clin Colorectal Cancer. 2017 Sep; 16 (): 165-172https://doi.org/10.1016/j.clcc.2016.09.012

    • Kant P.
    • Sainsbury A.
    • Reed K.R.
    • et al.

    Rectal epithelial cell mitosis and expression of macrophage migration inhibitory factor are increased 3 years after Roux-en-Y gastric bypass (RYGB) for morbid obesity: implications for long-term neoplastic risk following RYGB.

    Gut. 2011 Jul; 60 (): 893-901https://doi.org/10.1136/gut.2010.230755

  • Afshar S, Malcomson F, Kelly SB, Seymour K, Woodcock S, Mathers JC. Biomarkers of Colorectal Cancer Risk Decrease 6 months After Roux-en-Y Gastric Bypass Surgery. Obes Surg. 2018 Apr;28(4):945-954. doi: 10.1007/s11695-017-2953-6. PMID: 28990150; PMCID: PMC5880852.

  • Appleton GV, Wheeler EE, Al-Mufti R, Challacombe DN, Williamson RC. Rectal hyperplasia after jejunoileal bypass for morbid obesity. Gut. 1988 Nov;29(11):1544-1548. doi: 10.1136/gut.29.11.1544. PMID: 3209111; PMCID: PMC1433847.

  • Kant P, Perry SL, Dexter SP, Race AD, Loadman PM, Hull MA. Mucosal biomarkers of colorectal cancer risk do not increase at 6 months following sleeve gastrectomy, unlike gastric bypass. Obesity (Silver Spring). 2014 Jan;22(1):202-210. doi: 10.1002/oby.20493. PMID: 23625552.

    • Aron-Wisnewsky J.
    • Doré J.
    • Clement K.

    The importance of the gut microbiota after bariatric surgery.

    Nat Rev Gastroenterol Hepatol. 2012 Oct; 9 (): 590-598https://doi.org/10.1038/nrgastro.2012.161

    • Anhê F.F.
    • Varin T.V.
    • Schertzer J.D.
    • Marette A.

    The Gut Microbiota as a Mediator of Metabolic Benefits after Bariatric Surgery.

    Can J Diabetes. 2017 Aug; 41 (): 439-447https://doi.org/10.1016/j.jcjd.2017.02.002

  • The effects of bariatric surgery on gut microbiota in patients with obesity: a review of the literature.

    Biosci Microbiota Food Health. 2019; 38 (): 3-9https://doi.org/10.12938/bmfh.18-018

    • Palleja A.
    • Kashani A.
    • Allin K.H.
    • et al.

    Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota.

    Genome Med. 2016 Jun 15; 8 (): 67https://doi.org/10.1186/s13073-016-0312-1

  • Tremaroli V, Karlsson F, Werling M, et al. Roux-en-Y Gastric Bypass and Vertical Banded Gastroplasty Induce Long-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation. Cell Metab. 2015 Aug 4;22(2):228-238. doi: 10.1016/j.cmet.2015.07.009. PMID: 26244932; PMCID: PMC4537510.

    • Furet J.P.
    • Kong L.C.
    • Tap J.
    • et al.

    Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers.

    Diabetes. 2010 Dec; 59 (): 3049-3057https://doi.org/10.2337/db10-0253

  • Zhang H, DiBaise JK, Zuccolo A, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2365-2370. doi: 10.1073/pnas.0812600106. Epub 2009 Jan 21. PMID: 19164560; PMCID: PMC2629490.

  • Graessler J, Qin Y, Zhong H, et al. Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters. Pharmacogenomics J. 2013 Dec;13(6):514-522. doi: 10.1038/tpj.2012.43. Epub 2012 Oct 2. PMID: 23032991.

    • Kong L.C.
    • Tap J.
    • Aron-Wisnewsky J.
    • et al.

    Gut microbiota after gastric bypass in human obesity: increased richness and associations of bacterial genera with adipose tissue genes.

    Am J Clin Nutr. 2013 Jul; 98 (): 16-24https://doi.org/10.3945/ajcn.113.058743

  • Damms-Machado A, Mitra S, Schollenberger AE, et al. Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption. Biomed Res Int. 2015;2015:806248. doi: 10.1155/2015/806248. Epub 2015 Feb 1. PMID: 25710027; PMCID: PMC4330959.

    • Tabasi M.
    • Eybpoosh S.
    • Siadat S.D.
    • Elyasinia F.
    • Soroush A.
    • Bouzari S.

    Modulation of the Gut Microbiota and Serum Biomarkers After Laparoscopic Sleeve Gastrectomy: a 1-Year Follow-Up Study.

    Obes Surg. 2021 May; 31 (): 1949-1956https://doi.org/10.1007/s11695-020-05139-2

    • Farin W.
    • Oñate F.P.
    • Plassais J.
    • et al.

    Impact of laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy on gut microbiota: a metagenomic comparative analysis.

    Surg Obes Relat Dis. 2020 Jul; 16 (): 852-862https://doi.org/10.1016/j.soard.2020.03.014

  • Shao Y, Ding R, Xu B, et al. Alterations of Gut Microbiota After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy in Sprague-Dawley Rats. Obes Surg. 2017 Feb;27(2):295-302. doi: 10.1007/s11695-016-2297-7. PMID: 27440168.

  • Ciobârcă D, Cătoi AF, Copăescu C, Miere D, Crișan G. Bariatric Surgery in Obesity: Effects on Gut Microbiota and Micronutrient Status. Nutrients. 2020 Jan 16;12(1):235. doi: 10.3390/nu12010235. PMID: 31963247; PMCID: PMC7019602.

  • Smith CD, Herkes SB, Behrns KE, Fairbanks VF, Kelly KA, Sarr MG. Gastric acid secretion and vitamin B12 absorption after vertical Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 1993 Jul;218(1):91-96. doi: 10.1097/00000658-199307000-00014. PMID: 8328834; PMCID: PMC1242905.

  • Steenackers N, Vanuytsel T, Augustijns P, Tack J, Mertens A, Lannoo M, Van der Schueren B, Matthys C. Adaptations in gastrointestinal physiology after sleeve gastrectomy and Roux-en-Y gastric bypass. Lancet Gastroenterol Hepatol. 2021 Mar;6(3):225-237. doi: 10.1016/S2468-1253(20)30302-2. PMID: 33581761.

  • Walker AW, Duncan SH, McWilliam Leitch EC, Child MW, Flint HJ. pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon. Appl Environ Microbiol. 2005 Jul;71(7):3692-3700. doi: 10.1128/AEM.71.7.3692-3700.2005. PMID: 16000778; PMCID: PMC1169066.

  • Pryde SE, Duncan SH, Hold GL, Stewart CS, Flint HJ. The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett. 2002 Dec 17;217(2):133-139. doi: 10.1111/j.1574-6968.2002.tb11467.x. PMID: 12480096.

    • Miquel S.
    • Martín R.
    • Rossi O.
    • et al.

    Faecalibacterium prausnitzii and human intestinal health.

    Curr Opin Microbiol. 2013 Jun; 16 (): 255-261https://doi.org/10.1016/j.mib.2013.06.003

    • Tamanai-Shacoori Z.
    • Smida I.
    • Bousarghin L.
    • et al.

    Roseburia spp.: a marker of health?.

    Future Microbiol. 2017 Feb; 12 (): 157-170https://doi.org/10.2217/fmb-2016-0130

    • Li J.V.
    • Ashrafian H.
    • Bueter M.
    • et al.

    Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk.

    Gut. 2011 Sep; 60 (): 1214-1223https://doi.org/10.1136/gut.2010.234708

  • Li JV, Reshat R, Wu Q, et al. Experimental bariatric surgery in rats generates a cytotoxic chemical environment in the gut contents. Front Microbiol. 2011 Sep 13;2:183. doi: 10.3389/fmicb.2011.00183. PMID: 21949514; PMCID: PMC3171674.

    • Weiss T.S.
    • Bernhardt G.
    • Buschauer A.
    • et al.

    Polyamine levels of human colorectal adenocarcinomas are correlated with tumor stage and grade.

    Int J Colorectal Dis. 2002 Nov; 17 (): 381-387https://doi.org/10.1007/s00384-002-0394-7

    • Novita Sari I.
    • Setiawan T.
    • Seock Kim K.
    • Toni Wijaya Y.
    • Won Cho K.
    • Young Kwon H.

    Metabolism and function of polyamines in cancer progression.

    Cancer Lett. 2021 Oct 28; 519 (): 91-104https://doi.org/10.1016/j.canlet.2021.06.020

    • Farriol M.
    • Segovia-Silvestre T.
    • Castellanos J.M.
    • Venereo Y.
    • Orta X.

    Role of putrescine in cell proliferation in a colon carcinoma cell line.

    Nutrition. 2001 Nov-Dec; 17 (): 934-938https://doi.org/10.1016/s0899-9007(01)00670-0

    • Grosheva I.
    • Zheng D.
    • Levy M.
    • et al.

    High-Throughput Screen Identifies Host and Microbiota Regulators of Intestinal Barrier Function.

    Gastroenterology. 2020 Nov; 159 (): 1807-1823https://doi.org/10.1053/j.gastro.2020.07.003

  • Sobhani I, Tap J, Roudot-Thoraval F, et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One. 2011 Jan 27;6(1):e16393. doi: 10.1371/journal.pone.0016393. PMID: 21297998; PMCID: PMC3029306.

    • Wu N.
    • Yang X.
    • Zhang R.
    • et al.

    Dysbiosis signature of fecal microbiota in colorectal cancer patients.

    Microb Ecol. 2013 Aug; 66 (): 462-470https://doi.org/10.1007/s00248-013-0245-9

  • Wang T, Cai G, Qiu Y, et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J. 2012 Feb;6(2):320-329. doi: 10.1038/ismej.2011.109. Epub 2011 Aug 18. PMID: 21850056; PMCID: PMC3260502.

  • Ma Y, Zhang Y, Xiang J, et al. Metagenome Analysis of Intestinal Bacteria in Healthy People, Patients With Inflammatory Bowel Disease and Colorectal Cancer. Front Cell Infect Microbiol. 2021 Feb 26;11:599734. doi: 10.3389/fcimb.2021.599734. Erratum in: Front Cell Infect Microbiol. 2021 Sep 27;11:765843. PMID: 33738265; PMCID: PMC7962608.

  • Kostic AD, Gevers D, Pedamallu CS, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 2012 Feb;22(2):292-298. doi: 10.1101/gr.126573.111. Epub 2011 Oct 18. PMID: 22009990; PMCID: PMC3266036.

  • He T, Cheng X, Xing C. The gut microbial diversity of colon cancer patients and the clinical significance. Bioengineered. 2021 Dec;12(1):7046-7060. doi: 10.1080/21655979.2021.1972077. PMID: 34551683; PMCID: PMC8806656.

  • Zhu Q, Jin Z, Wu W, et al. Analysis of the intestinal lumen microbiota in an animal model of colorectal cancer. PLoS One. 2014 Mar 6;9(6):e90849. doi: 10.1371/journal.pone.0090849. PMID: 24603888; PMCID: PMC3946251.

  • Zackular JP, Baxter NT, Iverson KD, et al. The gut microbiome modulates colon tumorigenesis. mBio. 2013 Nov 5;4(6):e00692-13. doi: 10.1128/mBio.00692-13. PMID: 24194538; PMCID: PMC3892781.

  • Saus E, Iraola-Guzmán S, Willis JR, Brunet-Vega A, Gabaldón T. Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential. Mol Aspects Med. 2019 Oct;69:93-106. doi: 10.1016/j.mam.2019.05.001. Epub 2019 May 24. PMID: 31082399; PMCID: PMC6856719.

  • Kohoutova D, Smajs D, Moravkova P, et al. Escherichia coli strains of phylogenetic group B2 and D and bacteriocin production are associated with advanced colorectal neoplasia. BMC Infect Dis. 2014 Dec 24;14:733. doi: 10.1186/s12879-014-0733-7. PMID: 25540872; PMCID: PMC4300055.

    • Bonnet M.
    • Buc E.
    • Sauvanet P.
    • et al.

    Colonization of the human gut by E. coli and colorectal cancer risk.

    Clin Cancer Res. 2014 Feb 15; 20 (): 859-867https://doi.org/10.1158/1078-0432.CCR-13-1343

  • Kostic AD, Chun E, Robertson L, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013 Aug 14;14(2):207-215. doi: 10.1016/j.chom.2013.07.007. PMID: 23954159; PMCID: PMC3772512.

    • Ito M.
    • Kanno S.
    • Nosho K.
    • et al.

    Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway.

    Int J Cancer. 2015 Sep 15; 137 (): 1258-1268https://doi.org/10.1002/ijc.29488

    • Flanagan L.
    • Schmid J.
    • Ebert M.
    • et al.

    Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome.

    Eur J Clin Microbiol Infect Dis. 2014 Aug; 33 (): 1381-1390https://doi.org/10.1007/s10096-014-2081-3

  • Ajouz H, Mukherji D, Shamseddine A. Secondary bile acids: an underrecognized cause of colon cancer. World J Surg Oncol. 2014 May 24;12:164. doi: 10.1186/1477-7819-12-164. PMID: 24884764; PMCID: PMC4041630.

  • Patti ME, Houten SM, Bianco AC, et al. Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity (Silver Spring). 2009 Sep;17(9):1671-1677. doi: 10.1038/oby.2009.102. Epub 2009 Apr 9. PMID: 19360006; PMCID: PMC4683159.

  • Cole AJ, Teigen LM, Jahansouz C, Earthman CP, Sibley SD. The Influence of Bariatric Surgery on Serum Bile Acids in Humans and Potential Metabolic and Hormonal Implications: a Systematic Review. Curr Obes Rep. 2015 Dec;4(4):441-450. doi: 10.1007/s13679-015-0171-x. PMID: 26335653.

    • Nakatani H.
    • Kasama K.
    • Oshiro T.
    • Watanabe M.
    • Hirose H.
    • Itoh H.

    Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery.

    Metabolism. 2009 Oct; 58 (): 1400-1407https://doi.org/10.1016/j.metabol.2009.05.006

    • Ochsenkühn T.
    • Bayerdörffer E.
    • Meining A.
    • et al.

    Colonic mucosal proliferation is related to serum deoxycholic acid levels.

    Cancer. 1999 Apr 15; 85 (): 1664-1669

  • Steinbach G, Lupton J, Reddy BS, Kral JG, Holt PR. Effect of calcium supplementation on rectal epithelial hyperproliferation in intestinal bypass subjects. Gastroenterology. 1994 May;106(5):1162-1167. doi: 10.1016/0016-5085(94)90005-1. PMID: 8174878.

  • Bristol JB, Wells M, Williamson RC. Adaptation to jejunoileal bypass promotes experimental colorectal carcinogenesis. Br J Surg. 1984 Feb;71(2):123-126. doi: 10.1002/bjs.1800710216. PMID: 6692105.

  • Bernstein H, Bernstein C, Payne CM, Dvorak K. Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J Gastroenterol. 2009 Jul 21;15(27):3329-3340. doi: 10.3748/wjg.15.3329. PMID: 19610133; PMCID: PMC2712893.

  • Jia W, Xie G, Jia W. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat Rev Gastroenterol Hepatol. 2018 Feb;15(2):111-128. doi: 10.1038/nrgastro.2017.119. Epub 2017 Oct 11. PMID: 29018272; PMCID: PMC5899973.

  • Ocvirk S, O’Keefe SJ. Influence of Bile Acids on Colorectal Cancer Risk: Potential Mechanisms Mediated by Diet – Gut Microbiota Interactions. Curr Nutr Rep. 2017 Dec;6(4):315-322. doi: 10.1007/s13668-017-0219-5. Epub 2017 Nov 3. PMID: 29430336; PMCID: PMC5802424.

  • Shao T, Yang YX. Cholecystectomy and the risk of colorectal cancer. Am J Gastroenterol. 2005 Aug;100(8):1813-1820. doi: 10.1111/j.1572-0241.2005.41610.x. PMID: 16086719.

  • Lagergren J, Ye W, Ekbom A. Intestinal cancer after cholecystectomy: is bile involved in carcinogenesis? Gastroenterology. 2001 Sep;121(3):542-547. doi: 10.1053/gast.2001.27083. PMID: 11522737.

  • Kim SB, Kim KO, Kim TN. Prevalence and Risk Factors of Gastric and Colorectal Cancer after Cholecystectomy. J Korean Med Sci. 2020 Nov 2;35(42):e354. doi: 10.3346/jkms.2020.35.e354. PMID: 33140590; PMCID: PMC7606888.

  • Nguyen TT, Ung TT, Kim NH, Jung YD. Role of bile acids in colon carcinogenesis. World J Clin Cases. 2018 Nov 6;6(13):577-588. doi: 10.12998/wjcc.v6.i13.577. PMID: 30430113; PMCID: PMC6232560.

    • Bernstein H.
    • Bernstein C.
    • Payne C.M.
    • Dvorakova K.
    • Garewal H.

    Bile acids as carcinogens in human gastrointestinal cancers.

    Mutat Res. 2005 Jan; 589 (): 47-65https://doi.org/10.1016/j.mrrev.2004.08.001

  • Farup PG, Valeur J. Changes in Faecal Short-Chain Fatty Acids after Weight-Loss Interventions in Subjects with Morbid Obesity. Nutrients. 2020 Mar 18;12(3):802. doi: 10.3390/nu12030802. PMID: 32197409; PMCID: PMC7146446.

  • Juárez-Fernández M, Román-Sagüillo S, Porras D, et al. Long-Term Effects of Bariatric Surgery on Gut Microbiota Composition and Faecal Metabolome Related to Obesity Remission. Nutrients. 2021 Jul 23;13(8):2519. doi: 10.3390/nu13082519. PMID: 34444679; PMCID: PMC8397959.

    • Yu D.
    • Shu X.O.
    • Howard E.F.
    • Long J.
    • English W.J.
    • Flynn C.R.

    Fecal metagenomics and metabolomics reveal gut microbial changes after bariatric surgery.

    Surg Obes Relat Dis. 2020 Nov; 16 (): 1772-1782https://doi.org/10.1016/j.soard.2020.06.032

  • Dolara P, Caderni G, Salvadori M, et al. Fecal levels of short-chain fatty acids and bile acids as determinants of colonic mucosal cell proliferation in humans. Nutr Cancer. 2002;42(2):186-190. doi: 10.1207/S15327914NC422_6. PMID: 12416258.

  • Monleón D, Morales JM, Barrasa A, López JA, Vázquez C, Celda B. Metabolite profiling of fecal water extracts from human colorectal cancer. NMR Biomed. 2009 Apr;22(3):342-348. doi: 10.1002/nbm.1345. PMID: 19006102.

  • Segain JP, Raingeard de la Blétière D, Bourreille A, et al. Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn’s disease. Gut. 2000 Sep;47(3):397-403. doi: 10.1136/gut.47.3.397. PMID: 10940278; PMCID: PMC1728045.

  • Smith PM, Howitt MR, Panikov N, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science. 2013 Aug 2;341(6145):569-573. doi: 10.1126/science.1241165. Epub 2013 Jul 4. PMID: 23828891; PMCID: PMC3807819.

    • Rosignoli P.
    • Fabiani R.
    • De Bartolomeo A.
    • Fuccelli R.
    • Pelli M.A.
    • Morozzi G.

    Genotoxic effect of bile acids on human normal and tumour colon cells and protection by dietary antioxidants and butyrate.

    Eur J Nutr. 2008 Sep; 47 (): 301-309https://doi.org/10.1007/s00394-008-0725-8

  • Ruemmele FM, Schwartz S, Seidman EG, Dionne S, Levy E, Lentze MJ. Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway. Gut. 2003 Jan;52(1):94-100. doi: 10.1136/gut.52.1.94. PMID: 12477768; PMCID: PMC1773532.

  • Hague A, Elder DJ, Hicks DJ, Paraskeva C. Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int J Cancer. 1995 Jan 27;60(3):400-406. doi: 10.1002/ijc.2910600322. PMID: 7829251.

  • Hague A, Manning AM, Hanlon KA, Huschtscha LI, Hart D, Paraskeva C. Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int J Cancer. 1993 Sep 30;55(3):498-505. doi: 10.1002/ijc.2910550329. PMID: 8397167.

  • Donohoe DR, Collins LB, Wali A, Bigler R, Sun W, Bultman SJ. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol Cell. 2012 Nov 30;48(4):612-626. doi: 10.1016/j.molcel.2012.08.033. Epub 2012 Oct 11. PMID: 23063526; PMCID: PMC3513569.

  • Liberti MV, Locasale JW. The Warburg Effect: How Does it Benefit Cancer Cells? Trends Biochem Sci. 2016 Mar;41(3):211-218. doi: 10.1016/j.tibs.2015.12.001. Epub 2016 Jan 5. Erratum in: Trends Biochem Sci. 2016 Mar;41(3):287. Erratum in: Trends Biochem Sci. 2016 Mar;41(3):287. PMID: 26778478; PMCID: PMC4783224.

    • Bordonaro M.
    • Lazarova D.L.
    • Sartorelli A.C.

    Butyrate and Wnt signaling: a possible solution to the puzzle of dietary fiber and colon cancer risk?.

    Cell Cycle. 2008 May 1; 7 (): 1178-1183https://doi.org/10.4161/cc.7.9.5818



  • Source link

    Home  Articles  Disclaimer  Contact Us